Back to Results
First PageMeta Content
Pharmacia / Icaria / Ikaria / Greece / Pfizer / Kalamazoo County / Michigan / Upjohn


IKARIA® NAMES CHIEF SCIENCE OFFICER Clinton, NJ, July 15, 2010 – Ikaria, Inc. today announced that Martin Meglasson, Ph.D., will join Ikaria as Chief Science Officer. Dr. Meglasson will be responsible for activities r
Add to Reading List

Document Date: 2011-06-28 11:53:03

Open Document

File Size: 59,22 KB

Share Result on Facebook

City

Madison / Seattle / Port Allen / /

Company

The Upjohn Company / Pharmacia Inc. / Ligand Pharmaceuticals Incorporated / Pharmacia & Upjohn / Ikaria Inc. / Discovery Research / /

Country

Puerto Rico / Japan / United States / Canada / Australia / Mexico / /

Event

Employment Change / M&A / FDA Phase / /

IndustryTerm

manufacturing facility / pharmaceutical industry / drug product / treatment of hypoxic respiratory failure / care products / treatment for hepatorenal syndrome / /

MedicalCondition

pulmonary hypertension / subsequent congestive heart failure / hypoxic respiratory failure / acute myocardial infarction / /

Organization

FDA / /

Person

Douglas Greene / Clinton / Martin Meglasson / /

Position

CHIEF SCIENCE OFFICER / leader / Executive Vice President of Research and Development / Vice President of Discovery Research / Vice President / /

Product

INOMAX / INOtherapy® / /

ProvinceOrState

Wisconsin / Louisiana / Washington / /

Technology

drug development / /

URL

www.ikaria.com / /

SocialTag